KKRC
AGN

Kohlberg Kravis Roberts & Co’s Allergan plc AGN Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-244,700
Closed -$40M – 47
2017
Q4 		$40M Buy
+244,700
New +$43.9M 0.39% 22
2016
Q2 		– Sell
-72,000
Closed -$19.3M – 55
2016
Q1 		$19.3M Buy
+72,000
New +$20.6M 0.19% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's AGN Position: Q4 2016 in Review

Kohlberg Kravis Roberts & Co sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 16,500 shares — an estimated $3.8M sold.

Kohlberg Kravis Roberts & Co first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $13.2M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 16,500 Allergan plc shares in Q4 2016, an estimated $3.8M.
  • Kohlberg Kravis Roberts & Co first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Kohlberg Kravis Roberts & Co's Allergan plc position peaked at $13.2M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q4 2016, filed 14 Feb 2017.